Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael H Davidson

Showing results (11-20 of 300) with videos related to

Pageof 30
Sort By:
Current Atherosclerosis Reports|December 16, 2006
The PROACTIVE Study and reduction of cardiovascular events in patients with diabetesMichael H Davidson
Current Cardiology Reports|September 8, 2010
Should niacin be the preferred drug to add to a statin?Michael H Davidson
Journal of the American College of Cardiology|December 22, 2012
Low-density lipoprotein cholesterol, non-high-density lipoprotein, apolipoprotein, or low-density lipoprotein particle: what should clinicians measure?Michael H Davidson
Postgraduate Medicine|August 12, 2009
Reducing cardiovascular risk: trends in risk, risk assessment, and cholesterol managementMichael H Davidson
The American Journal of Medicine|June 7, 2002
A look to the future: new treatment guidelines and a perspective on statinsMichael H Davidson,
The American Journal of Cardiology|October 16, 2012
Cardiovascular risk factors in a patient with diabetes mellitus and coronary artery disease: therapeutic approaches to improve outcomes: perspectives of a preventive cardiologistMichael H Davidson
Current Treatment Options in Cardiovascular Medicine|June 23, 2012
HDL and CETP Inhibition: Will This DEFINE the Future?Michael H Davidson
Current Diabetes Reports|May 24, 2003
Combination lipid-lowering therapy in diabetesMichael H Davidson
Current Atherosclerosis Reports|December 29, 2010
Therapies targeting exogenous cholesterol uptake: new insights and controversiesMichael H Davidson
Journal of Clinical Lipidology|December 3, 2010
Counterpoint: Low-density lipoprotein cholesterol goals in patients with diabetes are adequately based on evidenceMichael H Davidson
Pageof 30

Showing results (11-20 of 300) with videos related to

Sort By:
Pageof 30
Current Atherosclerosis Reports|December 16, 2006
The PROACTIVE Study and reduction of cardiovascular events in patients with diabetesMichael H Davidson
Current Cardiology Reports|September 8, 2010
Should niacin be the preferred drug to add to a statin?Michael H Davidson
Journal of the American College of Cardiology|December 22, 2012
Low-density lipoprotein cholesterol, non-high-density lipoprotein, apolipoprotein, or low-density lipoprotein particle: what should clinicians measure?Michael H Davidson
Postgraduate Medicine|August 12, 2009
Reducing cardiovascular risk: trends in risk, risk assessment, and cholesterol managementMichael H Davidson
The American Journal of Medicine|June 7, 2002
A look to the future: new treatment guidelines and a perspective on statinsMichael H Davidson,
The American Journal of Cardiology|October 16, 2012
Cardiovascular risk factors in a patient with diabetes mellitus and coronary artery disease: therapeutic approaches to improve outcomes: perspectives of a preventive cardiologistMichael H Davidson
Current Treatment Options in Cardiovascular Medicine|June 23, 2012
HDL and CETP Inhibition: Will This DEFINE the Future?Michael H Davidson
Current Diabetes Reports|May 24, 2003
Combination lipid-lowering therapy in diabetesMichael H Davidson
Current Atherosclerosis Reports|December 29, 2010
Therapies targeting exogenous cholesterol uptake: new insights and controversiesMichael H Davidson
Journal of Clinical Lipidology|December 3, 2010
Counterpoint: Low-density lipoprotein cholesterol goals in patients with diabetes are adequately based on evidenceMichael H Davidson
Pageof 30